The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

first- time drug regimen

Oct 13, 2005

I have a cd4 count of 16 and viral load 500,000+. 39 years old, 5'10", 140lbs, symptoms minimal. My Dr. has perscribed Combivir + Sustiva as first drug treatment. Also received second opinion of Combivir + Kaletra. Please lend your opinion. thanks

Response from Dr. Pierone

You asked for it here it is - your third opinion Norvir, Reyataz, and Truvada.

There is nothing wrong with the first two choices by the way. Both are tried and true and would be expected to work.

In a situation with a very low CD4 count and high viral load there is a legitimate argument that can be made for starting with a more potent boosted PI regimen. However, a Sustiva-based regimen will often work even with a high viral load. The reason I suggested the regimen above is because Truvada is once daily and tends to be better tolerated than Combivir. Also, boosted Reyataz is given once daily, contains fewer pills, and is better tolerated than Kaletra. Again, this is not written in stone because of a dearth of direct comparative studies. But there are some trials underway which will probably help to better treatment decisions in the future. Good luck to you!

low cd4 counts, not rising and Hep C
When to Start Treatment

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint